Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
8th grade Avg
|
New words:
Alere, Angela, bad, biopharmaceutical, burden, caption, chronic, coinsurance, comprised, compromise, correctly, decided, denial, dollar, entirety, False, fine, gathering, hand, HITECH, imposition, leaving, Modification, newly, NexScreen, nonvested, payer, permissible, Promissory, publicly, referenced, return, statistical, surrender, surrendered, suspension, timetable, transmission, upgrade
Removed:
Abbott, ABI, absence, agricultural, assumed, BioMeditech, continuously, correct, country, directly, FASB, favorable, guarantee, history, inducement, intention, introduction, maturity, modified, occasionally, OTC, peripheral, practice, prescription, Princeton, recall, recalling, replace, resolution, Schmidt, Steven, sum, SUPPLEMENTARY, unsecured, visually, voluntarily
Filing tables
Filing exhibits
Related press release
MTOX similar filings
Filing view
External links
Exhibit 23 |
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statement Nos. 333-117198 on Form S-3/A and 333-117199 and 333-168922 on Form S-8 of our reports dated March 14, 2011, relating to the consolidated financial statements and financial statement schedule of MEDTOX Scientific, Inc., and the effectiveness of MEDTOX Scientific, Inc.’s internal control over financial reporting appearing in this Annual Report on Form 10-K of MEDTOX Scientific, Inc. for the year ended December 31, 2010.
Minneapolis, Minnesota
March 14, 2011